xxxxxx

DAFTAR PUSTAKA

1. Baziad A. Kontrasepsi hormonal. Jakarta: Yayasan Bina Pustaka Sarwono Prawirohardjo;2002.h.1-50

2. Saifuddin AB. Dinamika kependudukan dan keluarga berencana. Dalam: Wiknjosasro H, Saifuddin AB, Rachimhadhi T, penyunting. Ilmu kebidanan. Edisi ke-3. Jakarta: Yayasan Bina Pustaka Sarwono Prawirohardjo;2006.h.889-903

3. The American College of Obstetricians and Gynaecologists Committee. Contraceptives and congenital anomalies. Int J Gynecol Obstret. 1993; 42:316-7

4. Zierler S. Maternal drugs and congenital heart disease. J Am Col Obstet Gynecol. 1985;65:155-63

5. The Excecutive of the Society of Obstetricians and Gynaecologists of Canada. Principles of human teratology: drug, chemical, and infectious exposure. J Obstet Gynecol Com. 2007;199:911-6

6. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility. Edisi ke-7. Philadelphia:Williams & Wilkins;2005.h.861-903

7. Affandi B. Kontrasepsi. Dalam: Wiknjosasro H, Saifuddin AB, Rachimhadhi T, penyunting. Ilmu kebidanan. Edisi ke-2. Jakarta: Yayasan Bina Pustaka Sarwono Prawirohardjo;2006.h.905-21

8. Albar E. Kontrasepsi. Dalam: Wiknjosasro H, Saifuddin AB, Rachimhadhi T, penyunting. Ilmu kandungan. Edisi ke-2. Jakarta: Yayasan Bina Pustaka Sarwono Prawirohardjo;2007.h.543-51

9. Taber LA. Biophysical mechanisms of cardiac looping. Int J Dev Biol. 2006;50:323-32

10. Creazzo TL, Godt RE, Leatherbury L, Conway SJ, Kirby ML. Role of cardiac neural crest cells in cardiovascular development. Annu Rev Physiol. 1998;60:267-86

11. Zaffran S, Frasch M. Early signals in cardiac development. Circ Res. 2002;91:457-69

12. Waldo K, Zdanowicz M, Burch J, Kumiski D, Stadt H,Godt RE, et al. A novel role of cardiac neural crest in heart development. J Clin Invest. 1999;103:1499-1507

13. Abdulla R, Blew GA, Holterman MJ. Cardiovascular embryology. Pediatr Cardiol. 2004;25:191-200

14. Epstein JA. Cardiac development and implications for heart disease. N Engl J Med. 2010;17:1638-47

15. Roebiono PS, Rahaju AU, Sastroasmoro S. Embriogenesis kardiovaskular dan sirkulasi janin. Dalam: Sastroasmoro S, Madiyono B, penyunting. Buku ajar kardiologi anak. Jakarta: Yayasan Binarupa Aksara;1994. h.172-81

16. Srivastava D, Baldwin S. Molecular determinants of cardiac development. Dalam: Allen HD, Gutgesell HP, Clark EB, Driscoll DJ, penyunting. Moss and adams’ heart disease in infants, children, and adolescents. Edisi ke-6. Philadelphia: Williams & Wilkins;2001.h.12-9

Universitas Sumatera Utara

17. Prasodo AM. Penyakit jantung bawaan sianotik. Dalam: Sastroasmoro S, Madiyono B, penyunting. Buku ajar kardiologi anak. Jakarta: Yayasan Binarupa Aksara;1994.h.234-78

18. Madiyono B, Rahayuningsih SE, Sukardi R. Penanganan penyakit jantung pada bayi dan anak. Jakarta: Balai Penerbit FKUI; 2005.h.25-36

19. Dorfman AL, Geva T. Magnetic resonance imaging evaluation of congenital heart disease: conotruncal anomalies. J of Cardiovasc Magn Resonance. 2006;8:645-59

20. Obler D, Juraszek AL, Smoot LB, Natowitz MR. Double outlet right ventricle: aetiologies and associations. J Med Genet. 2008;45:481-97

21. Digilio MC, Casey B, Toscano A, Calabro R, Pacileo G, Marasini M, et al. Complete transposition of the great arteries:pattern of congenital heart disease in familial precurrence. Circulation. 2001;104:2809-14

22. Kirby ML. Pulmonary atresia or persistent truncus arteriosus. Circ Res. 2008;103:142-8

23. Bernstein D. Congenital heart disease. Dalam: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, penyunting. Nelson textbook of pediatrics. Edisi ke-18. Philadelphia: Saunders Elsevier;2007.h.1906-26

24. Park MK. Pediatric cardiology for practitioners. Edisi ke-4. St.Louis:Mosby Inc;2002.h.174-202

25. Sastroasmoro S, Madiyono B. Epidemiologi dan etiologi penyakit jantung bawaan. Dalam: Sastroasmoro S, Madiyono B, penyunting. Buku ajar kardiologi anak. Jakarta: Yayasan Binarupa Aksara;1994.h.165-90

26. Bracken. Oral contraception and congenital malformations in offspring:a review and meta-analysis of the prospective studies. J Obstret Gynecol. 1990;76:552-7

27. Grimes DA. Reversible contraception for women at high rik of fetal anomalies. J Am Acad Dermatol. 1987;17:148-55

28. Pizzo TSD, Sanseverino MTV, Mengue SS. Exposure to misoprostol and hormones during pregnancy and risk of congenital anomalies. Cad Saude Publica. 2008;24:1447-53

29. Czeizel AE, Kodajt I. A changing pattern in the association of oral contraceptives and the different groups of congenital limb deficiencies. Contraception.1995;51:19-24

30. Kaplan J, Hudgins L. Neonatal presentations of CHARGE Syndrome and VATER/VACTERL Association. NeoReviews. 2008;9:299-304

31. Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, et al. Noninherited risk factors and congenital cardiovascular defects:current knowledge:a scientific statement from the american heart association council on cardiovascular disease in the young:endorsed by the American academy of pediatrics. Circulation. 2007;115:2995-3014

32. Mone SM, Gillman MW, Miller TL, Herman EH, Lipshultz SE. Effects of environmental exposures on the cardiovascular system:prenatal period through adolescence. Pediatrics. 2004;113:1058-1069

33. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. New England J Med. 1998;338:1128-36


34. Bailey J, Knight A, Balcombe J. The future of teratology research is in vitro. Biogenic Amines J. 2005;19:97-145

35. Madiyono B, Moeslichan S, Sastroasmoro S, Budiman I, Purwanto SH. Perkiraan besar sample. Dalam: Sastroasmoro S, Ismael S, penyunting. Dasar-dasar metodologi penelitian klinis. Jakarta: Sagung Seto; 2008. h.302-30

36. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. New hypertension guidelines. N Eng J Med. 2003;23:93-4

37. Perkumpulan Endokrinologi Indonesia. Konsensus pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia. Jakarta: Perkeni; 2011. h.20-1

38. American Psychiatric Association. Diagnostic and statistical manual of mental disorders-text revision. Washington DC:APA:2000.h.188-98

39. Badan Pusat Statistik. Perkembangan beberapa indikator utama sosial ekonomi Indonesia. Jakarta: Badan Pusat Statistik:2011.h.31-3

40. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890-900

41. Pradat P, Francannet C, Harris JA, Robert E. The epidemiology of cardiovascular defect, part I: a study based on data from three large registries of congenital malformations. Pediatr Cardiol. 2003;24:195-221

42. Djer MM, Madiyono B. Tatalaksana penyakit jantung bawaan. Sari Pediatri. 2000;2:155-62

43. Harris JA, Francannet C, Pradat P, Robert E. The epidemiology of cardiovascular defects, part II:a study based on data from three large registries of congenital malformations. Pediatr Cardiol. 2003;24:222-35

44. Goldmuntz E, Clark BJ, Mitchell LE, Jawad AF, Cuneo BF, Reed L, et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol.1998;32:492-8

45. Reefhuis J, Honein MA,. Maternal age and non chromosal birth defects, Atlanta 1968-2000:teenager or thirty something, who it ask risk?. Birth defects Res A Clin Mol Teratol. 2004;70:572-9

46. Carmichael SL, Ma C, Shaw GM. Sosioeconomic measures, orofacial clefts, and conotruncal heart defects in California. Birth Defects Res A Clin Mol Teratol. 2009;85:850-7

47. Botto LD, Correa A, Erickson JD. Racial and temporal variation in the prevalence of heart defects. Pediatrics. 2001;107:32-3

48. Shaw GM, Carmichael SL, Nelson V. Congenital malformations in offspring of Vietnamese women in California, 1985-97. Teratology. 2002;65:121-4

49. Adams MM, Mulinare J, Dooley K. Risk factors for conotruncal cardiac defects in Atlanta. J Am Coll Cardiol. 1989;14:432-42

50. Brent RL. Nongenital malformations following exposure to progestational drugs: the last chapter of an erroneous allegation. Birth defect Res. 2005;73:906-18

51. Levy EP, Cohen A, Fraser FC. Hormone treatment during pregnancy and congenital heart disease. Lancet. 1973;1:611-2

52. Katz Z, Lancet M, Skornik J. Teratogenicity of progestogens given during the first trimester of pregnancy. Obstet Gynecol. 1985;65:775-81


53. Santis MD, Cavaliere AF. Failure of emergency contraceptive levonorgestrel and the risk of adverse effects in pregnancy and on fetal development: an observational cohort study. Fert and Ster. 2005;84:296-9

54. Posaci C, Smitz J, Camus M, Osmanagaoglu K, Devroey P. Progesterone for the luteal support of assisted reproductive technologies: clinical options. Human Reproduction. 2000;15:129-48

55. Fisher B, Rose NC, Carey JC. Principles and practice of teratology for the obstetrician. Clinical Obstetrics and Gynecology. 2008;51:106-18


xxxxxx

Documents